Propionic acid and fasudil as treatment against rotenone toxicity in an in vitro model of Parkinson's disease
Open accessThe DOI matches its Crossref record; 55 of the 57 references it cites were found in a registry or an index.
Abstract
Parkinson’s disease (PD) is a multifactorial neurodegenerative disease. In recent years, several studies demonstrated that the gastroenteric system and intestinal microbiome influence central nervous system function. The pathological mechanisms triggered thereby change neuronal function in neurodegenerative diseases including dopaminergic neurons in Parkinson´s disease. In this study, we employed a model system for PD of cultured primary mesencephalic cells and used the pesticide rotenone to model dopaminergic cell damage. We examined neuroprotective effects of the Rho kinase inhibitor Fasudil and the short chain fatty acid (SCFA) propionic acid on primary neurons in cell morphological assays, cell survival, gene and protein expression. Fasudil application resulted in significantly enhanced neuritic outgrowth and increased cell survival of dopaminergic cells. The application of propionic acid primarily promoted cell survival of dopaminergic cells against rotenone toxicity and increased neurite outgrowth to a moderate extent. Interestingly, Fasudil augmented gene expression of synaptophysin whereas gene expression levels of tyrosine hydroxylase (TH) were substantially increased by propionic acid. Concerning protein expression propionic acid treatment increased STAT3 levels but did not lead to an increased phosphorylation indicative of pathway activation. Our findings indicate that both Fasudil and propionic acid treatment show beneficial potential in rotenone-lesioned primary mesencephalic cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A recent study on the effect of propionate on rotenone-treated dopaminergic neurons showed that the survival rate of TH + dopaminergic neurons increased significantly, indicating that propionic acid increased the expression of the TH gene, decreased the expression of the a-synuclein gene, and increased the expression of intracellular STAT3 protein to promote neuroprotection.197”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [197]
Experimental — accuracy not yet measuredIn the citing paper
“propionate supplementation was able to promote neurite outgrowth, tyrosine hydroxylase (TH) expression and dopaminergic cell survival in vitro [112]”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [112]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 1×
“Since the publication of the Braak hypothesis of aSyn propagation from gut to brain [6], the gut–brain-axis has become an important focus of PD research.”
BackgroundKalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622 · cited 2×
“In in vivo models of PD, an increase in microglia activation was observed after enhancement of aSyn-mediated pathology by SCFA [10].”
BackgroundThe Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication
Silva, Y. P., Bernardi, A., & Frozza, R. L. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00025 · Cited by 3,043 · cited 3×
“Besides its promoting effect on neural progenitor cells [30], the direct impact on SCFA on neurons is poorly investigated, but an influence of neurotransmitter synthesis and levels of neurotrophic factors has been observed [22].”
BackgroundMethodColonic Health: Fermentation and Short Chain Fatty Acids
Wong, J. M. W., de Souza, R., Kendall, C. W. C., Emam, A., & Jenkins, D. J. A. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200603000-00015 · Cited by 2,739 · cited 2×
“SCFA are produced by anaerobic bacteria like Fusobacterium through the fermentation of dietary carbohydrates such as dietary fibers [12,13].”
BackgroundGut microbiota are related to Parkinson's disease and clinical phenotype
Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968 · cited 1×
“Clinical studies show alteration in the microbiome in fecal samples of PD patients compared to healthy controls [7].”
BackgroundRegulation of inflammation by short chain fatty acids
Vinolo, M. A. R., Rodrigues, H. G., Nachbar, R. T., & Curi, R. (2011) · Nutrients · doi:10.3390/nu3100858 · Cited by 1,724 · cited 2×
“SCFA as has been Molecules 2020, 25, 2502 10 of 15 demonstrated to influence inflammatory cells like microglia or leukocytes and effect the production of pro- and anti-inflammatory cytokines like interleukin 10 (IL-10) or tumor necrosis factor alpha (TNFα) [47,51].”
BackgroundLi, N., Ragheb, K., Lawler, G., Sturgis, J., Rajwa, B., Melendez, J. A., & Robinson, J. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210432200 · Cited by 1,433 · cited 3×
“Rotenone inhibits the mitochondrial respiratory chain which leads to decreased adenosine triphosphate (ATP) levels, oxidative stress through reactive oxygen species (ROS) and ultimately to neurite damage and apoptosis.”
BackgroundUnger, M. M., Spiegel, J., Dillmann, K.-U., Grundmann, D., Philippeit, H., Bürmann, J., Faßbender, K., Schwiertz, A., & Schäfer, K.-H. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.08.019 · Cited by 1,159
Cited by
Short chain fatty acids: Microbial metabolites for gut-brain axis signalling
O'Riordan, K. J., Collins, M. K., Moloney, G. M., Knox, E. G., Aburto, M. R., Fülling, C., Morley, S. J., Clarke, G., Schellekens, H., & Cryan, J. F. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111572 · Cited by 713
Role of microbiota-derived short-chain fatty acids in nervous system disorders
Mirzaei, R., Bouzari, B., Hosseini-Fard, S. R., Mazaheri, M., Ahmadyousefi, Y., Abdi, M., Jalalifar, S., Karimitabar, Z., Teimoori, A., Keyvani, H., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111661 · Cited by 386
Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy
Shen, Y., Fan, N., Ma, S., Cheng, X., Yang, X., & Wang, G. (2025) · MedComm · doi:10.1002/mco2.70168 · Cited by 301
The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
Wang, Q., Luo, Y., Ray Chaudhuri, K., Reynolds, R., Tan, E.-K., & Pettersson, S. (2021) · Brain · doi:10.1093/brain/awab156 · Cited by 281
Feeding gut microbes to nourish the brain: unravelling the diet–microbiota–gut–brain axis
Schneider, E., O’Riordan, K. J., Clarke, G., & Cryan, J. F. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01108-6 · Cited by 272
“Addressing this deficit, propionate treatment promoted dopaminergic cell survival in an in vitro PD mouse model 134 .”
Wang, Z., Wang, C., Yuan, B., Liu, L., Zhang, H., Zhu, M., Chai, H., Peng, J., Huang, Y. H., Zhou, S., et al. (2025) · Microbiome · doi:10.1186/s40168-024-02001-w · Cited by 132
Potential roles of gut microbiota and microbial metabolites in Parkinson’s disease
Zheng, S.-Y., Li, H.-X., Xu, R.-C., Miao, W.-T., Dai, M.-Y., Ding, S.-T., & Liu, H.-D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101347 · Cited by 101
Varesi, A., Campagnoli, L. I. M., Fahmideh, F., Pierella, E., Romeo, M., Ricevuti, G., Nicoletta, M., Chirumbolo, S., & Pascale, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012289 · Cited by 88
Parkinson's Disease Is Associated with Impaired Gut–Blood Barrier for Short‐Chain Fatty Acids
Yang, X., Ai, P., He, X., Mo, C., Zhang, Y., Xu, S., Lai, Y., Qian, Y., & Xiao, Q. (2022) · Movement Disorders · doi:10.1002/mds.29063 · Cited by 82
“Two subsequent studies showed that PPA promotes survival of dopaminergic cells against rotenone toxicity in the PD model, and that orally administered PPA rescued dopaminergic neuronal loss and motor deficits in PD mice.(40,41) Altogether, combining an exclusive association between PPA and PD status, characterized fir…”
ResultGuo, B., Zhang, J., Zhang, W., Chen, F., & Liu, B. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2272769 · Cited by 96
“As shown in Figure 5, propionate affects neurotransmitter synthesis in dopaminergic neurons by upregulating tryptophan 5-hydroxylase 1 and increasing TH levels (Ostendorf et al. 2020).”
Duan, W.-X., Wang, F., Liu, J., & Liu, C. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01123-9 · Cited by 95
Chen, S., & Lin, C. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00839-6 · Cited by 93
Wu, G., Jiang, Z., Pu, Y., Chen, S., Wang, T., Wang, Y., Xu, X., Wang, S., Jin, M., Yao, Y., et al. (2022) · BMC Neurology · doi:10.1186/s12883-021-02544-7 · Cited by 67
“An in vitro experiment showed that treatment with propionic acid prevented dopaminergic neurons from the neurotoxicity of rotenone and enhanced the outgrowth of neurites [26].”
BackgroundCentral and peripheral regulations mediated by short-chain fatty acids on energy homeostasis
Luo, P., Lednovich, K., Xu, K., Nnyamah, C., Layden, B. T., & Xu, P. (2022) · Translational research · doi:10.1016/j.trsl.2022.06.003 · Cited by 65
Li, J., Li, J., Tang, B., & Guo, J. (2023) · European Journal of Neurology · doi:10.1111/ene.15848 · Cited by 65
“SCFAs are generally considered beneficial microbial metabolites for human health [33], and supplementation with SCFAs can significantly improve or even reverse PD symptoms [34, 35].”
BackgroundLan, Z., Tang, X., Lu, M., Hu, Z., & Tang, Z. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e26377 · Cited by 44
Wang, C., Yang, M., Liu, D., & Zheng, C. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113865 · Cited by 44
Wu, Q. J., Dong, J., Bai, X., Jiang, Y., Li, J., Fan, S., Cheng, Y., & Jiang, G. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174974 · Cited by 38
Bi, M., Feng, L., He, J., Liu, C., Wang, Y., Jiang, H., & Liu, S. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101759 · Cited by 34
Comprehensive analysis of the cerebrospinal fluid and serum metabolome in neurological diseases
Otto, C., Kalantzis, R., Kübler, D., Kühn, A. A., Böld, T., Regler, A., Strathmeyer, S., Wittmann, J., Ruprecht, K., & Heelemann, S. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03218-0 · Cited by 34
“In an in vitro model of PD using cultured primary mesencephalic cells treated with the pesticide rotenone, which induces dopaminergic cell damage, propionic acid promoted cell survival of rotenone-treated dopaminergic cells [14].”
BackgroundParkinson's Disease and the Gut: Models of an Emerging Relationship
Bindas, A. J., Kulkarni, S., Koppes, R. A., & Koppes, A. N. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.03.071 · Cited by 28
Naringenin/naringin therapeutic effects and the role of intestinal microflora in them
Huang, X., Wu, H., Wu, X. W., Su, W., & Li, P. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107871 · Cited by 33
Liu, J., Chen, Q., & Su, R. (2024) · Medicine · doi:10.1097/md.0000000000037960 · Cited by 25
“[137] Several strategies for modulating SCFA levels in patients with PD have been proposed.”
BackgroundPropionic acid induces alterations in mitochondrial morphology and dynamics in SH-SY5Y cells
Buchanan, E., Mahony, C., Bam, S., Jaffer, M. A., MacLeod, S. J., Mangali, A., van der Watt, M., de Wet, S., Theart, R. P., Jacobs, C., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-40130-8 · Cited by 26
Effects of a probiotic suspension Symprove™ on a rat early-stage Parkinson’s disease model
Sancandi, M., Caro, C. D., Cypaite, N., Marascio, N., Avagliano, C., Marco, C. D., Russo, E., Constanti, A., & Mercer, A. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.986127 · Cited by 25
“, IL-1β, IL-6 and TNF-α) were significantly increased in plasma and the anti-inflammatory cytokine IL-10 was reduced along with an increased concentration of circulating LPS and reduced concentrations of the gut microbial SCFA metabolites butyrate and propionate, considered (at least experimentally) as neuroprotective…”
BackgroundShort-chain fatty acids in the context of Parkinson’s disease
Metzdorf, J., & Tönges, L. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.308089 · Cited by 23
Self-citationDong, Y., Qi, Y., Chen, J., Han, S., Su, W., Ma, X., Yu, Y., & Wang, Y. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04038-2 · Cited by 22
“Interventions involving specific SCFAs have been shown to alleviate PD symptoms [58].”
BackgroundFlavanones as Modulators of Gut Microbiota and Cognitive Function
Cichoń, N., Szelenberger, R., Stela, M., Podogrocki, M., Gorniak, L., & Bijak, M. (2025) · Molecules · doi:10.3390/molecules30102203 · Cited by 21
“This discovery highlights the potential role of SCFAs in modulating dopaminergic activity by influencing key enzymes involved in dopamine production [73].”
Huang, P., Zhang, P., Du, J., Gao, C., Liu, J., Tan, Y., & Chen, S. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00554-5 · Cited by 21
“Studies have shown that propionic acid promotes the survival of dopaminergic neurons against rotenone toxicity in the PD model 30 and that orally administered propionic acid rescues dopaminergic neuronal loss and motor de fi cits in PD mice 31 .”
Schikora, J., Kiwatrowski, N., Förster, N., Selbach, L., Ostendorf, F., Pallapies, F., Hasse, B., Metzdorf, J., Gold, R., Mosig, A., et al. (2021) · Cells · doi:10.3390/cells10040931 · Cited by 19
“Therefore, approaches to prevent neuronal death [13–15], to replace neuronal cells [16] or to modulate inflammation and targeting aSYN have been followed [3,15].”
BackgroundResultSelf-citationImplications of Gut-Brain axis in the pathogenesis of Psychiatric disorders
Taniguchi, K., Ikeda, Y., Nagase, N., Tsuji, A., Kitagishi, Y., & Matsuda, S. (2021) · AIMS bioengineering · doi:10.3934/bioeng.2021021 · Cited by 12
“Consistent with this, the applications of propionic acid mostly promote cell survival of dopaminergic cells [64].”
BackgroundThe Intricate Interplay: Microbial Metabolites and the Gut‐Liver‐Brain Axis in Parkinson's Disease
Kishanchand, D. K., A., A. K. K., Chandrababu, K., Philips, C. A., Sivan, U., & Chakrapani, P. S. B. (2025) · Journal of Neuroscience Research · doi:10.1002/jnr.70016 · Cited by 15
Unveiling the significance of synaptic proteins in parkinson's pathogenesis: A review
Soni, R., & Shah, J. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.140789 · Cited by 10
Li, X., Wang, S., Duan, S., Long, L., Zhuo, L., Peng, Y., Xiong, Y., Li, S., Peng, X., Yan, Y., et al. (2023) · ACS Omega · doi:10.1021/acsomega.3c04277 · Cited by 9
Du, J., Zhang, P., Tan, Y., Gao, C., Liu, J., Huang, M., Li, H., Shen, X., Huang, P., & Chen, S. (2024) · Movement Disorders · doi:10.1002/mds.29803 · Cited by 10
“21 Our study also showed that fecal SFCA levels (propionic, acetic, and butyric acid) were decreased in iRBD patients, which was not reported in previous studies.”
Chen, J., Zhu, L., Wang, F., Zhu, Y., Chen, J., Liang, C., Liu, B., Pang, A., & Yang, X. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04765-0 · Cited by 11
“Cellular experiments indicate that propionic acid enhances the survival of dopaminergic neurons in the presence of rotenone and moderately promotes neurite outgrowth [33].”
The role of gut-derived short-chain fatty acids in Parkinson's disease
Saadh, M. J., Mustafa, A. N., Mustafa, M. A., Renuka Jyothi, S., Dabis, H. K., Prasad, G. V. S., Mohammad, I. J., Adnan, A., & Idan, A. H. (2024) · Neurogenetics · doi:10.1007/s10048-024-00779-3 · Cited by 9
“Propionic acid stimulated the transcriptional activation of α-syn in primary mesencephalic dopamine neurons that were treated with rotenone, according to early research [255].”
Yao, Q., Chen, L., Cai, Y., Li, C., Wen, S., Yang, C. Z., Zhang, Q., Zeng, Y., Zheng, S., Zou, J., et al. (2024) · International Journal of Medical Sciences · doi:10.7150/ijms.94335 · Cited by 6
“Increasing SCFA levels are generally considered beneficial for health [54], and PD symptoms can be mitigated or even eliminated by introducing SCFAs or reestablishing gut flora [55, 56].”
BackgroundSupplementation of the Probiotic LLH135 Reduces Oxidative Stress in a Model of Hemiparkinsonism
Flores-Soto, M. E., Nápoles-Medina, A. Y., Tejeda-Martínez, A. R., Solís-Pacheco, J. R., Chaparro-Huerta, V., Gutiérrez-Sevilla, J. E., & Aguilar‐Uscanga, B. R. (2025) · Behavioural Neurology · doi:10.1155/bn/8401392 · Cited by 4
“Furthermore, propionic acid has been shown to be an important fatty acid with immunomodulatory and neuroprotective properties by inhibiting dopaminergic cell death [44] and causing increased neurite outgrowth [45].”
Ma, W., Yuan, X., Liu, Y., Wang, Q., Zhang, Y., Dong, P., & Zhou, C. (2025) · Medicine · doi:10.1097/md.0000000000044035 · Cited by 3
An, K., Qu, Y., Li, J., Wang, D., Mao, Z., & Xue, Z. (2025) · Nutritional Neuroscience · doi:10.1080/1028415x.2025.2558119 · Cited by 3
“The survival of dopaminergic cells against rotenone toxicity and tyrosine hydroxylase (TH) expression were also promoted by the administration of propionic acid [61].”
Duran‐Cruz, V., Hernández, S., & Ortíz, I. (2024) · Engineering Reports · doi:10.1002/eng2.12858 · Cited by 5
Intestinal dysbiosis leads to the reduction in neurochemical production in Parkinson’s disease (PD)
Kumar, R., & Kumar, R. (2025) · International review of neurobiology · doi:10.1016/bs.irn.2025.03.004 · Cited by 3
Du, J., Huang, P., Zhang, P., Gao, C., Liu, J., Huang, M., Li, H., Shen, X., Tan, Y., & Chen, S. (2024) · Research Square · doi:10.21203/rs.3.rs-5182069/v1
Biological relationship between Parkinson's disease and gallstone disease
Jiang, C., Ma, J., Mu, J., Fu, Y., Zhao, Y., You, Y., Cui, Z., & Guo, C. (2025) · Neuroprotection/Neuroprotection (Chichester, England. Print) · doi:10.1002/nep3.70021
Otto, C., Kalantzis, R., Kübler, D., Kühn, A. A., Böld, T., Regler, A., Strathmeyer, S., Wittmann, J. J., Ruprecht, K., & Heelemann, S. (2024) · Figshare · doi:10.6084/m9.figshare.27115999
Metadata
- Authors
- Ostendorf, F., Metzdorf, J., Gold, R., Haghikia, A., & Tönges, L.
- Affiliations
- St. Josef-Hospital (DE)
- Corresponding author
- Tönges, Lars
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2020-05-28
- Volume
- 25
- Issue
- 11
- Pages
- 2502
- ISSN
- 1420-3049 (ISSN-L)
- PMC
- PMC7321113
- OpenAlex
- W3031730348
- Semantic Scholar
- 1be7d31728d0df084db15e3c8ed9ffec5a96f339
- Cited by
- 46
- References
- 57
- Citations by year
- 2025: 12 · 2024: 12 · 2023: 7 · 2022: 8 · 2021: 6 · 2020: 1
- FWCI
- 2.38
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Molecules (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Dokumentenrepositorium der RUB (Ruhr University Bochum) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Deutsche Forschungsgemeinschaft
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Keywords
- Parkinson's disease, rotenone toxicity, fasudil, propionic acid, short-chain fatty acids, Rho kinase inhibition, dopaminergic neurons, neuroprotection, neurite outgrowth, synaptophysin, tyrosine hydroxylase, STAT3, gut-brain axis, gut microbiota
- MeSH terms
- Animals, Cell Survival, Cells, Cultured, Female, Immunohistochemistry, Parkinson Disease, Pregnancy, Propionates, Rotenone, Tyrosine 3-Monooxygenase, Blotting, Western, Rats, Sprague-Dawley, Neuroprotective Agents, 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine, Rats, rho-Associated Kinases, Dopaminergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.